Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.

Bereczky S, Lindegren G, Karlberg H, Akerström S, Klingström J, Mirazimi A.

J Gen Virol. 2010 Jun;91(Pt 6):1473-7. doi: 10.1099/vir.0.019034-0. Epub 2010 Feb 17.

PMID:
20164263
2.

Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells.

Peyrefitte CN, Perret M, Garcia S, Rodrigues R, Bagnaud A, Lacote S, Crance JM, Vernet G, Garin D, Bouloy M, Paranhos-Baccalà G.

J Gen Virol. 2010 Jan;91(Pt 1):189-98. doi: 10.1099/vir.0.015701-0. Epub 2009 Oct 7.

PMID:
19812268
4.

Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.

Akinci E, Yilmaz M, Bodur H, Ongürü P, Bayazit FN, Erbay A, Ozet G.

Int J Infect Dis. 2009 Sep;13(5):560-3. doi: 10.1016/j.ijid.2008.08.027. Epub 2008 Dec 27.

5.

Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.

Andersson I, Karlberg H, Mousavi-Jazi M, Martínez-Sobrido L, Weber F, Mirazimi A.

J Med Virol. 2008 Aug;80(8):1397-404. doi: 10.1002/jmv.21222.

PMID:
18551619
6.

Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.

Yilmaz M, Aydin K, Akdogan E, Sucu N, Sonmez M, Omay SB, Koksal I.

J Clin Virol. 2008 Aug;42(4):415-7. doi: 10.1016/j.jcv.2008.03.003. Epub 2008 Apr 22.

PMID:
18434247
7.

Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients.

Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, Georges-Courbot MC, Papa A, Günther S, Drosten C.

Emerg Infect Dis. 2007 Jul;13(7):1097-100. doi: 10.3201/eid1307.070068.

8.

Treatment of Crimean-Congo hemorrhagic fever.

Ergonul O.

Antiviral Res. 2008 Apr;78(1):125-31. Epub 2007 Dec 3. Review.

PMID:
18096251
9.

Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses.

Gowen BB, Holbrook MR.

Antiviral Res. 2008 Apr;78(1):79-90. Epub 2007 Nov 6. Review.

PMID:
18036672
10.

Regulation of interferon-gamma during innate and adaptive immune responses.

Schoenborn JR, Wilson CB.

Adv Immunol. 2007;96:41-101. Review.

PMID:
17981204
11.

Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.

Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Ongürü P, Kubar A.

Clin Infect Dis. 2007 Oct 1;45(7):e96-100. Epub 2007 Aug 23.

12.

Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever.

Purnak T, Selvi NA, Altundag K.

Med Hypotheses. 2007;68(4):924-5. Epub 2006 Oct 23. No abstract available.

PMID:
17056187
13.

Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST.

J Virol. 2006 Sep;80(17):8834-42.

14.

Cytokine levels in Crimean-Congo hemorrhagic fever.

Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A.

J Clin Virol. 2006 Aug;36(4):272-6. Epub 2006 Jun 9.

PMID:
16765637
15.

Crimean-Congo haemorrhagic fever.

Ergönül O.

Lancet Infect Dis. 2006 Apr;6(4):203-14. Review.

PMID:
16554245
16.

Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.

Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B.

J Infect Dis. 2006 Apr 1;193(7):941-4. Epub 2006 Feb 22.

17.

Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.

Andersson I, Lundkvist A, Haller O, Mirazimi A.

J Med Virol. 2006 Feb;78(2):216-22.

PMID:
16372299
18.

Mechanisms of action of ribavirin against distinct viruses.

Graci JD, Cameron CE.

Rev Med Virol. 2006 Jan-Feb;16(1):37-48. Review.

PMID:
16287208
19.

Crimean-Congo hemorrhagic fever.

Whitehouse CA.

Antiviral Res. 2004 Dec;64(3):145-60. Review.

PMID:
15550268
20.

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP.

Lancet. 2003 Dec 13;362(9400):1953-8.

PMID:
14683653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk